IMNM Stock Summary and Trading Ideas (Immunome | NASDAQ:IMNM)

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

Immunome trades on the NASDAQ stock market under the symbol IMNM.

As of July 17, 2026, IMNM stock price climbed to $22.32 with 662,163 million shares trading.

IMNM has a beta of 0.88, meaning it tends to be less sensitive to market movements. IMNM has a correlation of 0.03 to the broad based SPY ETF.

IMNM has a market cap of $2.53 billion. This is considered a Mid Cap stock.

Last quarter Immunome reported $0 in Revenue and -$.48 earnings per share. This fell short of revenue expectation by $-533,336 and exceeded earnings estimates by $.08.

In the last 3 years, IMNM traded as high as $30.96 and as low as $5.15.

The top ETF exchange traded funds that IMNM belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWO.

IMNM has outperformed the market in the last year with a return of +113.6%, while the SPY ETF gained +19.5%. However, in the most recent history, IMNM shares have underperformed the stock market with its stock returning -9.4% in the last 3 month period and -5.5% for the last 2 week period, while SPY has returned +4.9% and -0.2%, respectively.

IMNM support price is $21.34 and resistance is $23.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IMNM shares will trade within this expected range on the day.